{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:07:47Z","timestamp":1759334867638,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.jaad.2011.04.024","type":"journal-article","created":{"date-parts":[[2011,8,13]],"date-time":"2011-08-13T15:26:28Z","timestamp":1313249188000},"page":"e100-e101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Acute generalized exanthematous pustulosis (AGEP) caused by telavancin"],"prefix":"10.1016","volume":"65","author":[{"given":"Jake E.","family":"Turrentine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer W.","family":"Dharamsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Miedler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit G.","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2009","series-title":"Vibativ (telavancin) [package insert]","key":"10.1016\/j.jaad.2011.04.024_bib1"},{"key":"10.1016\/j.jaad.2011.04.024_bib2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1085-5629(96)80037-X","article-title":"Acute generalized exanthematous pustulosis","volume":"15","author":"Beylot","year":"1996","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaad.2011.04.024_bib3","unstructured":"Traynor K. Telavancin approved for serious skin infections. American Society of Health-System Pharmacists. Available at: http:\/\/www.ashp.org\/. Accessed Sept 14, 2009."},{"key":"10.1016\/j.jaad.2011.04.024_bib4","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1517\/14656566.9.12.2197","article-title":"A new lipoglycopeptide: telavancin","volume":"9","author":"Nannini","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jaad.2011.04.024_bib5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1592\/phco.30.1.80","article-title":"A comparative review of the lipoglycopeptides: oritavancin, dalbavancin, and telavancin","volume":"30","author":"Guskey","year":"2010","journal-title":"Pharmacotherapy"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962211005470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962211005470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:22:26Z","timestamp":1759270946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962211005470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0190962211005470"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2011.04.024","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute generalized exanthematous pustulosis (AGEP) caused by telavancin","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2011.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}